Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

Figure 1

The box and whisker plot shows the median value and 10-90 percentiles of biomarkers, ESR1 and 14-3-3-σ , measured in the serum of the individuals in each of the three study groups: Healthy Controls ( HC ); Disease-Free Breast Cancer (DFBC) ; and Metastatic Breast Cancer (MBC). 14-3-3-σ values significantly differed between the DFBC and MBC groups (Dunn test, P > 0.0001) and between each of these and the HC group (P < 0.001).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us